What is the maximum per day infusion dose of Lasix (furosemide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Per Day Infusion Dose of Furosemide

The maximum daily dose of intravenous furosemide is 240 mg in the first 24 hours for acute heart failure, with a maximum infusion rate of 4 mg/min, though higher doses up to 600 mg/day may be used in severe edematous states with careful monitoring. 1, 2

Standard Maximum Dosing by Clinical Context

Acute Heart Failure

  • Total furosemide dose should remain <100 mg in the first 6 hours and <240 mg during the first 24 hours 1
  • Initial IV bolus: 20-40 mg over 1-2 minutes, with higher doses (up to 80 mg) for patients already on chronic oral diuretics 1
  • Continuous infusion: 5-10 mg/hour, with maximum infusion rates not exceeding 4 mg/min 1
  • Doses of 250 mg and above must be given by infusion over 4 hours to prevent ototoxicity 1

Cirrhosis with Ascites

  • Maximum oral dose: 160 mg/day, typically combined with spironolactone 3, 1
  • Initial dose: 40 mg/day, increased every 2-3 days up to 160 mg/day 3
  • Exceeding 160 mg/day indicates diuretic resistance requiring alternative strategies (large volume paracentesis) rather than further dose escalation 1
  • High doses are associated with severe electrolyte disturbance and metabolic alkalosis 3

Severe Edematous States

  • The FDA label indicates doses may be carefully titrated up to 600 mg/day in severe edematous states 2
  • In refractory cardiac failure, doses up to 700 mg/day (mean maintenance) have been used successfully, with peak doses reaching 8 g/day in one case report 4
  • However, in chronic renal insufficiency, maximal response is attained with single IV doses of 120-160 mg, with no benefit from larger single doses 5

Critical Infusion Rate Considerations

  • Infusions must be administered over 5-30 minutes to avoid hearing loss 1
  • Maximum infusion rate: 4 mg/min 1
  • Rapid IV administration increases risk of ototoxicity, particularly at high doses 1, 2

Mandatory Monitoring Requirements

During High-Dose Infusion

  • Urine output: hourly monitoring 1
  • Blood pressure: every 15-30 minutes in first 2 hours 1
  • Electrolytes (sodium, potassium): within 6-24 hours 1
  • Renal function: within 24 hours 1
  • Bladder catheter placement recommended for rapid assessment of treatment response 1

Ongoing Monitoring

  • Daily weights targeting 0.5-1.0 kg loss per day 1
  • Electrolytes every 3-7 days during initial titration 1
  • Serum creatinine and sodium concentration, particularly during first weeks 1

Absolute Contraindications to Dose Escalation

Stop furosemide immediately if any of the following develop: 1

  • Severe hyponatremia (serum sodium <120-125 mmol/L)
  • Severe hypokalemia (<3 mmol/L)
  • Progressive renal failure or acute kidney injury
  • Anuria
  • Marked hypotension (SBP <90 mmHg without circulatory support)
  • Worsening hepatic encephalopathy (in cirrhotic patients)
  • Incapacitating muscle cramps

Management of Inadequate Response

Rather than escalating furosemide beyond 160-240 mg/day, consider combination therapy: 1

  • Add thiazide diuretic (hydrochlorothiazide 25 mg orally)
  • Add aldosterone antagonist (spironolactone 25-50 mg orally)
  • Sequential nephron blockade is more effective than monotherapy escalation 1

Alternative Strategies

  • In acute pulmonary edema: IV nitroglycerin is superior to high-dose furosemide alone 1
  • In cirrhosis exceeding 160 mg/day: large volume paracentesis with albumin replacement 1
  • In refractory cases: consider venovenous isolated ultrafiltration 1

Common Pitfalls to Avoid

  • Do not administer furosemide to hypotensive patients expecting hemodynamic improvement—it worsens tissue perfusion and precipitates cardiogenic shock 1
  • Do not exceed 6 mg/kg/day for periods longer than 1 week in pediatric patients 1
  • Do not use furosemide to prevent or treat acute kidney injury—only for managing volume overload that complicates AKI 1
  • Avoid evening doses causing nocturia and poor adherence 1
  • Do not escalate beyond 80-160 mg daily without adding a second diuretic due to ceiling effect 1

Special Population Considerations

Pediatric Patients

  • Maximum dose: 6 mg/kg/day 1
  • Doses greater than 6 mg/kg/day not recommended for >1 week 1
  • Monitor for nephrocalcinosis/nephrolithiasis, especially in premature infants 2

Elderly Patients

  • Start at low end of dosing range due to decreased renal function 2
  • More likely to experience toxic reactions due to impaired renal function 2

Renal Insufficiency

  • In chronic renal insufficiency (creatinine clearance <20 ml/min), maximal response attained with 120-160 mg single IV doses 5
  • No benefit from larger single doses in this population 5

References

Guideline

Furosemide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High dose furosemide in refractory cardiac failure.

European heart journal, 1985

Related Questions

Can another push dose of Lasix (furosemide) be administered to a patient with impaired renal function and suboptimal diuretic response?
How is the braking phenomenon of furosemide (loop diuretic) managed?
What is the recommended dosage of furosemide (Lasix) for an adult patient?
What is the appropriate treatment with PO Lasix (furosemide) for a patient with mild interstitial edema, left lung base infiltrate, and small pleural effusion, and impaired renal function (creatinine 1.6)?
Can I continue IV Lasix (Furosemide) in this patient?
What are the guidelines for anticoagulation in a patient with cerebral venous sinus thrombosis (CVST) and moderate hemorrhagic elements?
What is the best course of treatment for a patient with recurrent volvulus after undergoing a sigmoidectomy (removal of the sigmoid colon)?
Can achalasia cardia (a swallowing disorder characterized by the inability of food to pass through the esophagus) be mistaken for pseudoachalasia (a condition that mimics achalasia, often caused by an underlying malignancy) on contrast-enhanced computed tomography (CECT) scans in adults presenting with symptoms of dysphagia, regurgitation, and weight loss?
What is the recommended anesthesia regimen for a patient undergoing below the knee amputation, considering their medical history and potential allergies or sensitivities?
What are the risks and considerations for using Tryptomer (Amitriptyline) in pregnant women?
A patient presents with coccydynia, having recently lost weight while taking weight loss medication, and reports soreness in the tailbone area when sitting or lying down, possibly due to perceived loss of gluteus maximus muscle mass, what are the next steps in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.